Wong Alvin F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jun 6, 2022
Insider Transaction Report
Form 4
Wong Alvin F
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-06-02$1.92/sh−587$1,129→ 61,447 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.